As Sox9 has previously been implicated in the maintenance of the mammary stem cell state47,48 and was consistently associated with stem cell features in a panel of breast cancer cell lines49, we proceeded to use Sox9 expression as a surrogate marker of stemness in the PyMT model. The gene discussed is SOX9; the disease is breast carcinoma.